Hannover Re : Very little upside potential, so the risk for a correction is significant
Entry price | Target | Stop-loss | Potential |
---|
€109.35 |
€105 |
€110.25 |
+3.98% |
---|
Up substantially over the past few weeks, shares in Hannover Rückversicherung should pause in their rise close to the major resistance around 110.25 EUR.
Summary● The company usually posts poor financials for mid or long term investments.
● The company has poor fundamentals for a short-term investment strategy.
Strengths● The group usually releases upbeat results with huge surprise rates.
● The company is one of the best yield companies with high dividend expectations.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Weaknesses● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● Technically, the stock approaches a strong medium-term resistance at EUR 110.25.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● For the past seven days, analysts have been lowering their EPS expectations for the company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.